Zhang Zhe-Rui, Li Jin-Hang, Li Shang, Liu Ai-Lin, Hoi Pui-Man, Tian Hai-Yan, Ye Wen-Cai, Lee Simon Ming-Yuen, Jiang Ren-Wang
State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macao, P.R. China.
College of Pharmacy, Jinan University, Guangzhou, P.R. China.
PLoS One. 2014 Jul 3;9(7):e100416. doi: 10.1371/journal.pone.0100416. eCollection 2014.
Natural products present in low quantity in herb medicines constitute an important source of chemical diversity. However, the isolation of sufficient amounts of these low abundant constituents for structural modification has been a challenge for several decades and subsequently halts research on the utilization of this important source of chemical entities for drug discovery and development. And, pro-angiogenic therapies are being explored as options to treat cardio-cerebral vascular diseases and wound healing recently. The present study investigates the pro-angiogenic potential of tanshinone derivatives produced by one-pot synthesis using zebrafish model.
METHODOLOGY/PRINCIPAL FINDINGS: In order to address the difficulty of chemical modification of low abundant constituents in herb medicines, a novel one-pot combinatorial modification was used to diversify a partially purified tanshinone mixture from Salvia miltiorrhiza. This led to the isolation of ten new imidazole-tanshinones (Compounds 1-10) and one oxazole-tanshinone (Compound 11), the structures of which were characterized by spectroscopic methods in combination with single-crystal X-ray crystallographic analysis. The angiogenesis activities of the new tanshinone derivatives were determined in an experimental model of chemical-induced blood vessels damage in zebrafish. Of all the tested new derivatives, compound 10 exhibited the most potent vascular protective and restorative activity with an EC50 value of 0.026 µM. Moreover, the mechanism underlying the pro-angiogenesis effect of 10 probably involved the VEGF/FGF-Src-MAPK and PI3K-P38 signalling pathways by gene expression analysis and a blocking assay with pathways-specific kinase inhibitors.
CONCLUSIONS/SIGNIFICANCE: Taken together, our study demonstrated the more distinctive pro-angiogenic properties of 10 than other tanshinones and revealed 10 has potential for development as a pro-angiogenic agent for diseases associated with insufficient angiogenesis. Our results highlighted the great potential of adopting a newly modified one-pot approach to enhance the chemical diversity and biological activities of constituents from natural products regardless of their abundances.
草药中含量较低的天然产物是化学多样性的重要来源。然而,几十年来,分离出足够量的这些低丰度成分以进行结构修饰一直是一项挑战,这也因此阻碍了利用这一重要化学实体来源进行药物发现和开发的研究。此外,促血管生成疗法最近正被探索作为治疗心脑血管疾病和伤口愈合的选择。本研究使用斑马鱼模型研究了通过一锅法合成产生的丹参酮衍生物的促血管生成潜力。
方法/主要发现:为了解决草药中低丰度成分化学修饰的困难,采用了一种新型的一锅组合修饰方法,使丹参中部分纯化的丹参酮混合物多样化。这导致分离出10种新的咪唑-丹参酮(化合物1-10)和1种恶唑-丹参酮(化合物11),其结构通过光谱方法结合单晶X射线晶体学分析进行表征。在斑马鱼化学诱导血管损伤的实验模型中测定了新丹参酮衍生物的血管生成活性。在所有测试的新衍生物中,化合物10表现出最强的血管保护和修复活性,EC50值为0.026 μM。此外,通过基因表达分析和使用途径特异性激酶抑制剂的阻断试验,化合物10促血管生成作用的潜在机制可能涉及VEGF/FGF-Src-MAPK和PI3K-P38信号通路。
结论/意义:综上所述,我们的研究表明化合物10比其他丹参酮具有更独特的促血管生成特性,并揭示了化合物10有潜力开发成为一种用于血管生成不足相关疾病的促血管生成剂。我们的结果突出了采用新改良的一锅法来增强天然产物成分的化学多样性和生物活性的巨大潜力,无论其丰度如何。